Search
Bio Rad Laboratories Inc
BIOAdd to Watchlist
381.570USD
+12.570+3.41%
Close 11-06 16:00（ET）
10.20BMarket Cap
63.38P/E TTM
After-hours 19:00 (ET)381.570USD-0.510-0.13%
After-hours 19:00 (ET)Bio Rad Laboratories Inc (BIO) Stock Price Target & Forecast
Analyst Rating
Based on 3 analysts giving stock ratings to Bio Rad Laboratories Inc in the past month.
Hold
0 Strong Buy
1 Buy
1 Hold
1 Sell
0 Strong Sell
Target Price
362.500USD-2.60%
BIO Analyst Recommendation Trends
In the current month, BIO has received 1 Buy Ratings, 1 Hold Ratings, and 1 Sell Ratings. BIO average Analyst price target in the last month is 362.500.
2026-11
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
0
0
0
0
0
0
1
1
1
1
2
2
2
2
2
2
1
2
3
3
3
4
3
3
0
0
0
0
0
0
0
0
1
1
1
1
1
0
0
0
3
4
6
6
6
6
6
6
BIO Analyst Rating for Peer Comparison
Updated: Nov 5, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Stryker Corp
SYK
10
14
6
0
0
30
Medtronic PLC
MDT
8
11
10
0
0
29
Dexcom Inc
DXCM
13
12
4
0
0
29
Medline Ord Shs Class A
MDLN
10
12
6
0
0
28
Guardant Health Inc
GH
12
14
2
0
0
28
Abbott Laboratories
ABT
11
13
4
0
0
28
Zimmer Biomet Holdings Inc
ZBH
2
5
20
0
0
27
Insulet Corp
PODD
7
7
12
0
0
26
Tandem Diabetes Care Inc
TNDM
5
8
10
0
0
23
Repligen Corp
RGEN
5
12
4
0
0
21
Financial Forecasting
Based on analysts' estimates, BIO EPS is projected to reach 2.828 in FY2026Q4, following reported EPS of 17.125 in FY2026Q3. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
FY2027Q1
Forecast
1.98
1.75
2.23
2.83
2.83
Actual
-19.55
13.89
17.12
--
--
Surprise
-1085.52%
+694.52%
+669.65%
--
--
FAQs
What is Bio Rad Laboratories Inc's expected revenue for the next quarter?
Bio Rad Laboratories Inc's expected revenue is 688.65M.
What is Bio Rad Laboratories Inc's price target?
Analysts forecast that Bio Rad Laboratories Inc's price target is USD 395.00, with the highest forecast at USD 440.00 and the lowest forecast at USD 350.00.
How have Bio Rad Laboratories IncBIO's recent earnings per share performed?
The market expectation was USD 17.12, while Bio Rad Laboratories IncBIO's earnings per share (EPS) for the previous quarter was USD 13.89. EPS for the next quarter is expected at USD 2.83.
What is the analyst rating for Bio Rad Laboratories Inc?
Based on the ratings of Bio Rad Laboratories Inc's stock from 3 analysts, most analysts support a signal_hold trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as signal_hold. Please note that this is not trading advice. You still need to conduct your own analysis.